Maxillary Sinus Maxillary Sinus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Being between 18 and 65 years of age; Need for unilateral or bilateral maxillary sinus floor elevation for subsequent placement of osseointegrated implants; Presenting bone availability associated with the alveolar ridge adjacent to the maxillary sinus between 5mm and 7mm; Presenting good systemic health; Presenting at least 4 months of alveolar healing post-dental extraction
Exclusion criteria
Exclusion criteria: Smokers; Uncontrolled diabetics;Patients with chronic or aggressive periodontitis; Patients using medications that alter bone metabolism; Patients with chronic upper respiratory tract infections; Patients who chronically use anti-inflammatory drugs and antibiotics; Patients with bruxism; Alcoholics; Substance abusers; Pregnant or those who wish to become pregnant in the next year; History of radiotherapy treatment in the head and neck region; Patients with pathologies that affect bone metabolism; Patients who experienced a large rupture of the sinus membrane during surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The peri-implant bone level will be assessed using periapical radiographs and will be considered the primary outcome of this study. It is expected that implants placed in the different types of grafted areas will not show differences in this parameter greater than 0.5 mm | — |
Secondary
| Measure | Time frame |
|---|---|
| The cost-effectiveness analysis will be conducted prospectively and in parallel from the perspective of the dental service provider, simulating a private clinical setting within the Brazilian context. It is expected that no significant differences will be observed between the experimental groups in this study;The stability analysis of the implants will be one of the secondary variables in this study. It is expected that implants placed in areas grafted with alloplastic bone substitute using the transcrestal technique will exhibit 10% greater stability compared to short implants placed in non-grafted areas;The analysis of peri-implant parameters will be evaluated through clinical trials and will be considered secondary outcomes of this study. It is expected to observe that there will be no differences greater than 0.5 mm in probing depth and clinical attachment level parameters, and that there will be no differences greater than 5% in biofilm accumulation and peri-implant mucosal inflammation between the experimental groups of this study. | — |
Countries
BR
Contacts
Universidade Federal de Uberlândia